£795.00

The 2023 Report on Non-Small Cell Lung Cancer Therapeutics: World Market Segmentation by City

Price data last checked 9 day(s) ago - will refresh soon

View at Amazon

Price History & Forecast

Last 40 days • 40 data points (No recent data available)

Historical
Generating forecast...
£795.00 £755.25 £771.15 £787.05 £802.95 £818.85 £834.75 07 March 2026 16 March 2026 26 March 2026 05 April 2026 15 April 2026

Price Distribution

Price distribution over 40 days • 1 price levels

Days at Price
40 days 0 10 20 30 40 £795 Days at Price

Price Analysis

Most common price: £795 (40 days, 100.0%)

Price range: £795 - £795

Price levels: 1 different prices over 40 days

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
09 June 2022
Listed Since
11 July 2022

Similar Products You Might Like

The 2025-2030 World Outlook for Non-Small Cell Lung Cancer Therapeutics
99% match

The 2025-2030 World Outlook for Non-Small Cell Lung Cancer Therapeutics

£790.00 14 Apr 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States
99% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States

£520.00 10 Apr 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in India
99% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in India

£515.00 09 Apr 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in China
99% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in China

£495.00 14 Apr 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in Japan
99% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in Japan

£495.00 18 Mar 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancers in India
99% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancers in India

£515.00 14 Apr 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancers in the United States
99% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancers in the United States

£520.00 15 Apr 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancers in China
99% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancers in China

£495.00 15 Apr 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics for US Zip Codes
98% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics for US Zip Codes

£490.00 15 Apr 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancers in Japan
98% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancers in Japan

£495.00 18 Mar 2026
The 2023-2028 Outlook for Cancer Testing-Screening in India
98% match

The 2023-2028 Outlook for Cancer Testing-Screening in India

£515.00 14 Apr 2026
The 2023-2028 Outlook for Cancer Testing-Screening in the United States
98% match

The 2023-2028 Outlook for Cancer Testing-Screening in the United States

£520.00 11 Apr 2026
Lung Cancer Pathophysiology: An Interdisciplinary Approach: 8 (Interdisciplinary Cancer Research, 8)
98% match

Lung Cancer Pathophysiology: An Interdisciplinary Approach: 8 (Interdisciplinary Cancer Research, 8)

Springer

£121.25 18 Apr 2026
The 2016-2021 Outlook for Hematology and Oncology Products in Greater China
98% match

The 2016-2021 Outlook for Hematology and Oncology Products in Greater China

£595.00 14 Apr 2026
Fighting Lung Cancer with Conventional Therapies
98% match

Fighting Lung Cancer with Conventional Therapies

Nova Science Publishers Inc

£146.45 15 Apr 2026
The 2023-2028 Outlook for Cancer Vaccines in India
98% match

The 2023-2028 Outlook for Cancer Vaccines in India

£515.00 14 Apr 2026
The 2023 Report on Women's Diagnostic Breast Cancer Testing: World Market Segmentation by City
98% match

The 2023 Report on Women's Diagnostic Breast Cancer Testing: World Market Segmentation by City

£795.00 18 Apr 2026
The 2023-2028 Outlook for Cancer Vaccines in the United States
98% match

The 2023-2028 Outlook for Cancer Vaccines in the United States

£520.00 16 Apr 2026
The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in the United States
98% match

The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in the United States

£520.00 14 Apr 2026
The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in India
98% match

The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in India

£515.00 15 Apr 2026
The 2023 Report on Therapeutic Cancer Vaccines: World Market Segmentation by City
98% match

The 2023 Report on Therapeutic Cancer Vaccines: World Market Segmentation by City

£795.00 13 Apr 2026
Non-Small Cell Lung Cancer: Biomarker-Based Diagnosis and Therapy
98% match

Non-Small Cell Lung Cancer: Biomarker-Based Diagnosis and Therapy

Out of Stock 19 Apr 2026
The 2023 Report on Bladder Cancer Therapeutics: World Market Segmentation by City
98% match

The 2023 Report on Bladder Cancer Therapeutics: World Market Segmentation by City

£795.00 21 Apr 2026
The 2023 Report on Quality and Safety Reporting System for Healthcare Software: World Market Segmentation by City
98% match

The 2023 Report on Quality and Safety Reporting System for Healthcare Software: World Market Segmentation by City

£795.00 18 Apr 2026